niemann-pick diseases/seizures

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 17 rezilta yo

[Clinical features and gene mutation analysis of patients with Niemann-Pick disease type C].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Objective: To analyze the clinical manifestations, therapeutic efficacy, prognosis and characteristics of NPC1 mutation in Chinese patients with Niemann-Pick disease type C(NPC). Methods: Ten unrelated Chinese NPC patients were diagnosed by NPC1 mutation analysis from July 2013 to February 2017 in

Genotype/phenotype of 6 Chinese cases with Niemann-Pick disease type C.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Niemann-Pick disease type C (NP-C), caused by mutations of either NPC1 or NPC2 gene, is an inherited lysosomal lipid storage disorder that is difficult to be diagnosed and treated. NP-C is rarely reported in China and so far very few literatures are available for Chinese clinical workers. To better

Niemann-Pick disease type C: analysis of 7 patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Niemann-Pick disease type C (NP-C), derived from mutation of the NPC1 or NPC2 gene, is one of the recessive lysosomal lipid storage disorders that are difficult to diagnose and treat. Since NP-C has been rarely reported in China, we reviewed 7 patients with NP-C. METHODS The 7 patients

Decreased purinergic inhibition of synaptic activity in a mouse model of Niemann-Pick disease type C.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Niemann-Pick disease type C (NPC) is a progressive neurodegenerative disorder characterized by accumulation of free cholesterol in lysosomes, mainly due to a mutation in the NPC1 gene. The pathophysiological basis of the neural disorders in NPC, however, is not well understood. We found that the

Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Niemann-Pick disease type C (NPC) is an autosomal recessive neurovisceral lysosomal lipid storage disorder that leads to variable symptoms that include cognitive decline, ataxia, dystonia, cataplexy, vertical supranuclear gaze palsy, and seizures. Currently, there is no specific treatment for NPC

The Palliative Use of Intrathecal Baclofen in Niemann-Pick Disease Type C.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Niemann-Pick disease type C is a rare progressive genetic disorder that leads to the abnormal accumulation of lipids within various tissues of the body, including brain tissue and liver. There is a rapid progression of the disease, resulting in severe disability in only a few years after the first

Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for in vivo screening of candidate therapeutic compounds.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Niemann-Pick disease type C1 (NPC1) is a rare autosomal recessive lysosomal storage disease primarily caused by mutations in NPC1 NPC1 is characterized by abnormal accumulation of unesterified cholesterol and glycolipids in late endosomes and lysosomes. Common signs include neonatal jaundice,

Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Niemann-Pick disease type C is a rare inherited neurodegenerative disease involving impaired intracellular lipid trafficking and accumulation of glycolipids in various tissues, including the brain. Miglustat, a reversible inhibitor of glucosylceramide synthase, has been shown to be

Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Niemann-Pick disease, type C is a neurodegenerative, lysosomal storage disorder with a broad clinical spectrum and a variable age of onset. The absence of a universally accepted clinical outcome measure is an impediment to the design of a therapeutic trial for NPC. Thus, we developed a clinical

Lysosomal Storage Disorders in Indian Children with Neuroregression Attending a Genetic Center.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To study the etiology of neuroregression in children having deficiency of the lysosomal enzymes. METHODS Review of medical records. METHODS Specialized Genetic Center. METHODS 432 children aged 3 mo-18 y having regression in a learned skill, selected from 1453 patients referred for

Juvenile dystonic lipidosis: an unusual form of neurovisceral storage disease.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

An unusual neurovisceral lipid storage disorder in two unrelated juvenile patients manifested itself by dystonia and involuntary movements, with facial grimacing, dysarthria, gait difficulty, and impaired manual dexterity. Supranuclear paresis of vertical gaze and splenomegaly were present. Absent

[Medicinal therapy for lysosomal storage diseases].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Lysosomes contain several dozen different enzymes, mostly acid hydrolases. Materials not digested due to deficient lysosomal enzymes are usually large cellular molecules, which are deposited within the cells. The strategy for medicinal therapy of lysosomal storages disease may be to develop the

[Detection of vacuolated peripheral blood lymphocytes in screening for and diagnosis of lysosomal storage diseases].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Lysosomal storage diseases are a group of inherited disorders caused by deficiency of lysosomal enzymes or structural components. The manifestations of lysosomal storage diseases are complicated due to different enzyme deficiency. It has been reported that a range of metabolic diseases

Niemann-Pick type C: a potentially treatable disorder?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Niemann-Pick disease refers to a group of autosomal recessive lipid storage disorders associated with a variable degree of neurological manifestations in addition to other organ involvement. Niemann-Pick disease is divided into types A-C. Of interest to neurologists is Niemann-Pick type C because of

Congenital ocular motor apraxia associated with idiopathic generalized epilepsy in monozygotic twins.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Identical female twins (age 11 years) with congenital ocular motor apraxia and generalized idiopathic epilepsy are reported. Their presenting symptoms were a long history of abnormal head and eye movements. One twin developed partial sensory seizures. The patients underwent 16-channel EEG,

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye